scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.MLR.0000163641.86870.AF |
P698 | PubMed publication ID | 15908846 |
P2093 | author name string | Robert S Epstein | |
Kimberly A McGuigan | |||
Robert R Verbrugge | |||
Michael C Sokol | |||
P433 | issue | 6 | |
P304 | page(s) | 521-530 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Medical Care | Q15762119 |
P1476 | title | Impact of medication adherence on hospitalization risk and healthcare cost | |
P478 | volume | 43 |
Q36489370 | "It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting |
Q26744229 | A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for Pharmacists |
Q38655579 | A Narrative Review of Medication Adherence Educational Interventions for Health Professions Students |
Q40168078 | A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods |
Q36464886 | A Qualitative Study of Older Adults and Computer Use for Health Education: "It opens people's eyes" |
Q36961651 | A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study. |
Q37373446 | A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement. |
Q89949639 | A Scalable Smartwatch-Based Medication Intake Detection System Using Distributed Machine Learning |
Q90086375 | A Smartphone App to Improve Medication Adherence in Patients With Type 2 Diabetes in Asia: Feasibility Randomized Controlled Trial |
Q36905114 | A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness |
Q38168740 | A conceptual framework of patient satisfaction with a pharmacy adherence service. |
Q92005367 | A hybrid 4-item Krousel-Wood Medication Adherence Scale predicts cardiovascular events in older hypertensive adults |
Q93180366 | A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease |
Q35807939 | A novel once-daily fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer's disease: two phase I studies in healthy volunteers |
Q37134338 | A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile |
Q64227854 | A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis |
Q36657537 | A set of four simple performance measures reflecting adherence to guidelines predicts hospitalization: a claims-based cohort study of patients with diabetes |
Q33784870 | A single-item self-report medication adherence question predicts hospitalisation and death in patients with heart failure |
Q50071256 | A systematic review of the inclusion of mechanisms of action in NIH-funded intervention trials to improve medication adherence |
Q35107576 | A tool for prediction of risk of rehospitalisation and mortality in the hospitalised elderly: secondary analysis of clinical trial data |
Q37603117 | Adherence and health care costs |
Q51638920 | Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens |
Q38758759 | Adherence to Guidelines for Screening and Medication Use. |
Q99348028 | Adherence to Hypertension Medications and Lifestyle Recommendations among Underserved African American Middle-Aged and Older Adults |
Q91941886 | Adherence to Levothyroxine Tablet in Patients with Hypothyroidism |
Q36426092 | Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008. |
Q35519010 | Adherence to anti diabetic medication among patients with diabetes in eastern Uganda; a cross sectional study |
Q64078880 | Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon |
Q35205415 | Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients |
Q103812023 | Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarction |
Q36804187 | Adherence to cardiovascular medications: lessons learned and future directions |
Q58827325 | Adherence to combination therapy among ethnic Chinese patients: a cohort study |
Q64115069 | Adherence to immunomodulatory drugs in patients with multiple myeloma |
Q37453607 | Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling |
Q34514230 | Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer |
Q38103415 | Adherence to targeted oral anticancer medications. |
Q35083113 | Adherence to treatment guidelines and therapeutic regimens: a US claims-based benchmark of a commercial population |
Q36835874 | Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen |
Q34074861 | Adherence: a review of education, research, practice, and policy in the United States |
Q47587188 | Advantages to Using Social-Behavioral Models of Medication Adherence in Research and Practice |
Q34059929 | Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. |
Q90029383 | Agreement and Accuracy of Medication Persistence Identified by Patient Self-report vs Pharmacy Fill: A Secondary Analysis of the Cluster Randomized ARTEMIS Trial |
Q102212119 | Allopurinol adherence and its predictors in gout: a national cohort study in US veterans |
Q92138037 | Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study |
Q35570060 | An Analysis of Medication Adherence of Sooner Health Access Network SoonerCare Choice Patients |
Q35716882 | An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures. |
Q35891066 | An introductory pharmacy practice experience on improving medication adherence |
Q41500080 | An upper and lower bound of the Medication Possession Ratio |
Q47144755 | Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population-Based Cohort Study |
Q35661858 | Antihypertensive drug class and adherence: an electronic monitoring study |
Q33848968 | Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death |
Q35205378 | Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years |
Q35742576 | Antimigraine medication use and associated health care costs in employed patients |
Q39821714 | Assessing The Evidence For Value-Based Insurance Design |
Q37613103 | Assessment of Rheumatoid Arthritis Quality Process Measures and Associated Costs |
Q64242637 | Assessment of inter-rater agreement between physicians and their patients regarding medication adherence in a clinical questionnaire study |
Q92759449 | Assessment of patient medication adherence among the type 2 diabetes mellitus population with peripheral diabetic neuropathy in South India |
Q36292711 | Assessment of prescribers' knowledge of the cost of medications |
Q97884368 | Association Between the Level of Reported Good Medication Adherence and the Geographic Location of a Patient's Residence and Presence of a Glucometer Among Adult Patients with Diabetes in Ethiopia: A Systematic and Meta-Analysis |
Q58802373 | Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia |
Q61837464 | Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey |
Q84377693 | Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy |
Q36228968 | Association between sitagliptin adherence and self-monitoring of blood glucose |
Q37050954 | Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications |
Q92850903 | Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes |
Q37502125 | Association of Weight Loss and Medication Adherence Among Adults With Type 2 Diabetes Mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). |
Q35030012 | Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. |
Q34315403 | Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans |
Q47401058 | Associations Among Depressive Symptoms, Wellness, Patient Involvement, Provider Cultural Competency, and Treatment Nonadherence: A Pilot Study Among Community Patients Seen at a University Medical Center |
Q37194308 | Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database |
Q60913313 | Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases |
Q89835674 | Barriers to and competency with the use of metered dose inhaler and its impact on disease control among adult asthmatic patients in Ethiopia |
Q57645944 | Behavioral hazard in health insurance |
Q34405884 | Beliefs About Medicines and Self-reported Adherence Among Patients with Chronic Illness: A Study in Palestine |
Q36848894 | Beta testing of a network-based health literacy program tailored for older adults with hypertension |
Q36416892 | Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? |
Q37159292 | Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review. |
Q40393383 | Book club elective to facilitate student learning of the patient experience with chronic disease |
Q45982296 | Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Pol |
Q56828560 | Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response |
Q35775812 | Care transitions: a leverage point for safe and effective medication use in older adults--a mini-review |
Q36209929 | Carers' Medication Administration Errors in the Domiciliary Setting: A Systematic Review |
Q38205728 | Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease |
Q34629193 | Changes in hypertension treatment in the yaroslavl region of Russia: improvements observed between 2 cross-sectional surveys |
Q36373702 | Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes |
Q35649045 | Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders |
Q35210553 | Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension |
Q90356130 | Co-occurring reasons for medication nonadherence within subgroups of patients with hyperlipidemia |
Q34062383 | Cognitive dysfunction mediates the effects of poor physical fitness on decreased functional independence in heart failure |
Q37475092 | Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. |
Q40932155 | Combination evidence-based therapy is effective in the oldest 'old patients' following myocardial infarction. The "Salute e Benessere nell'Anziano" (SeBA) observational study. |
Q33981486 | Community-based participatory research and user-centered design in a diabetes medication information and decision tool |
Q40522165 | Comparative effectiveness of generic versus brand-name antiepileptic medications |
Q90597268 | Comparison of Student and Patient Perceptions for Medication Non-adherence |
Q46184082 | Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study |
Q36635305 | Comparison of methods to assess psychiatric medication adherence in methadone-maintained patients with co-occurring psychiatric disorder |
Q34065562 | Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling |
Q36186161 | Complementary and alternative medicine use amongst patients with cardiovascular disease in Singapore. |
Q36829007 | Compliance and fixed-dose combination therapy. |
Q26751351 | Conceptualizing type 2 diabetes and its management |
Q36887549 | Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes |
Q36975953 | Construction of a three-dimensional model of cardiovascular disease and deployment of a new method of fostering patient adherence to instruction |
Q34073709 | Continuity of Care for Elderly Patients with Diabetes Mellitus, Hypertension, Asthma, and Chronic Obstructive Pulmonary Disease in Korea |
Q92773202 | Continuity of care for newly diagnosed diabetic patients: A population-based study |
Q38162167 | Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations. |
Q35190998 | Cost implications to health care payers of improving glucose management among adults with type 2 diabetes |
Q36927439 | Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries |
Q34248283 | Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis |
Q36180337 | Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China |
Q28553675 | Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China |
Q37154533 | Cost-effectiveness of nurse practitioner/community health worker care to reduce cardiovascular health disparities |
Q56355786 | Cost-related medication non-adherence among U.S. adults with diabetes |
Q37191246 | Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes |
Q58761551 | Cost-related nonadherence to prescription medications in Canada: a scoping review |
Q92965851 | Could a methotrexate blood assay improve adherence? |
Q54155043 | Cultural Adaptation and Linguistic Validation of the Beliefs about Medicines Questionnaire in Malaysia. |
Q37035791 | Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials |
Q37014474 | Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions |
Q33871960 | Depression, medication adherence, and service utilization in systemic lupus erythematosus |
Q35207927 | Determinants of adherence to diabetes medications: findings from a large pharmacy claims database |
Q52382361 | Determinants of hospitalization in Chinese patients with type 2 diabetes receiving a peer support intervention and JADE integrated care: the PEARL randomised controlled trial. |
Q92888606 | Developing Preliminary Steps in a Pharmacist Communication - Patient Outcome Pathway |
Q57816956 | Development and Validation of a Novel General Medication Adherence Scale (GMAS) for Chronic Illness Patients in Pakistan |
Q37060624 | Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension |
Q37383507 | Development and reliability of a correction factor for family-reported medication adherence: pediatric inflammatory bowel disease as an exemplar. |
Q33606011 | Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? |
Q34583347 | Diabetes care and outcomes for American Indians and Alaska natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study |
Q36075113 | Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. |
Q37493801 | Diabetes technology--now and in the future |
Q47552104 | Dietary Patterns, Nutrition Knowledge, Lifestyle, and Health-Related Quality of Life: Associations with Anti-Hypertension Medication Adherence in a Sample of Australian Adults |
Q37191362 | Difference in Effectiveness of Medication Adherence Intervention by Health Literacy Level |
Q35887961 | Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). |
Q47107593 | Differences in medication adherence are associated with beliefs about medicines in asthma and COPD. |
Q37471683 | Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients |
Q58709115 | Disease-specific health literacy, disease knowledge, and adherence behavior among patients with type 2 diabetes in Taiwan |
Q40327176 | Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States. |
Q37809444 | Does Nurse Case Management Improve Implementation of Guidelines for Cardiovascular Disease Risk Reduction? |
Q33707663 | Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia? |
Q37808000 | Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes? |
Q36085521 | Does medication adherence following a copayment increase differ by disease burden? |
Q35089645 | Does medication adherence lower Medicare spending among beneficiaries with diabetes? |
Q36267592 | Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment? |
Q40236116 | Drug Side Effect Symptoms and Adherence to Antihypertensive Medication |
Q43442475 | Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study. |
Q38133767 | Drug adherence in patients taking oral anticoagulation therapy. |
Q36194054 | Drug adherence to biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept |
Q48302711 | Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity. |
Q37595422 | Duloxetine treatment adherence across mental health and chronic pain conditions |
Q35883262 | Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLAT |
Q33451226 | Economic Evaluation of Text-Messaging and Smartphone-Based Interventions to Improve Medication Adherence in Adolescents with Chronic Health Conditions: A Systematic Review |
Q47555825 | Economic impact of medication non-adherence by disease groups: a systematic review |
Q36809006 | Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial |
Q57165154 | Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial |
Q38130625 | Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients |
Q57215181 | Effect of improved medication adherence on health care costs in osteoporosis patients |
Q58778392 | Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients |
Q37313678 | Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications |
Q36600818 | Effect of switching medically vulnerable patients with uncontrolled diabetes from isophane insulin human to insulin glargine |
Q44334412 | Effect of the Medicare Prescription Drug Improvement and Modernization Act on the bottom line |
Q34149256 | Effective interventions to improve medication adherence in Type 2 diabetes: a systematic review |
Q34139114 | Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice. |
Q64088114 | Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial |
Q60300642 | Effectiveness of mailed letters to improve medication adherence among Medicare Advantage Plan participants with chronic conditions |
Q35164574 | Effectiveness of pharmaceutical care at discharge in the emergency department: study protocol of a randomized controlled trial |
Q34174844 | Effectiveness, safety and cost of drug substitution in hypertension |
Q36203999 | Effects of Adherence to Statin Therapy on Health Care Outcomes and Utilizations in Taiwan: A Population-Based Study |
Q34938270 | Effects of Physician Communication and Family Hardiness on Patient Medication Regimen Beliefs and Adherence |
Q36840933 | Effects of increased patient cost sharing on socioeconomic disparities in health care |
Q37166901 | Effects of the combinations of amlodipine/valsartan versus losartan/hydrochlorothiazide on left ventricular hypertrophy as determined with magnetic resonance imaging in patients with hypertension. |
Q34197044 | Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial |
Q34701662 | Efficacy of a brief multifactorial adherence-based intervention in reducing blood pressure: a randomized clinical trial. |
Q33702851 | Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial |
Q86867761 | Efficacy, safety, and tolerability of antihypertensive therapy with aliskiren/amlodipine in clinical practice in Austria. The RALLY (Rasilamlo long lasting efficacy) study |
Q37391005 | Electronically monitored medication adherence predicts hospitalization in heart failure patients |
Q44296662 | Emergency department care of seizure patients: demographic trends in southern Arizona |
Q37405395 | Engaging Gatekeeper-Stakeholders in Development of a Mobile Health Intervention to Improve Medication Adherence Among African American and Pacific Islander Elderly Patients With Hypertension |
Q92966471 | Epileptic patients' willingness to receive cell-phone based medication reminder in Northwest Ethiopia |
Q48052100 | Evaluating patients' comprehensibility of a standardized medication plan. |
Q35676539 | Evaluating the Potential Impact of Pharmacist Counseling on Medication Adherence Using a Simulation Activity |
Q34019299 | Evaluation of specialized medication packaging combined with medication therapy management: adherence, outcomes, and costs among Medicaid patients |
Q33621412 | Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea |
Q90342195 | Examining the Use of Real-World Evidence in the Regulatory Process |
Q47737746 | Exploring the implementation of a medication adherence programme by community pharmacists: a qualitative study. |
Q30621186 | Exploring the value of clinical data standards to predict hospitalization of home care patients |
Q57806051 | Extreme Price Variation for Generic Benign Prostatic Hyperplasia Medications |
Q36092252 | Factors affecting medication adherence in Lebanese patients with chronic diseases |
Q35642674 | Factors affecting medication adherence trajectories for patients with heart failure. |
Q36822915 | Factors affecting therapeutic compliance: A review from the patient's perspective |
Q37329642 | Factors associated with blood pressure control amongst adults with hypertension in Yaounde, Cameroon: a cross-sectional study |
Q92606082 | Factors associated with medication adherence in older patients: A systematic review |
Q34069718 | Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. |
Q84522885 | Factors influencing medication adherence and hypertension management revisited: recent insights from cancer survivors |
Q36253865 | Family and youth factors associated with health beliefs and health outcomes in youth with type 1 diabetes. |
Q36204996 | Financial reinforcers for improving medication adherence: findings from a meta-analysis |
Q91789051 | Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy |
Q84738764 | Fixed-dose combination therapy in hypertension: pros |
Q36913858 | Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease |
Q93083038 | Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada |
Q31049583 | Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data |
Q37699685 | Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population |
Q37702266 | Group-based trajectory modeling to assess adherence to biologics among patients with psoriasis |
Q37685504 | Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending? |
Q34385435 | Heart failure patients' experiences with continuity of care and its relation to medication adherence: a cross-sectional study |
Q34809210 | Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence |
Q49546448 | Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality |
Q34556420 | Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. |
Q37706942 | How costly is hospital quality? A revealed-preference approach |
Q38436502 | How important is mode of administration in treatments for rheumatic diseases and related conditions? |
Q35752951 | How patient cost-sharing trends affect adherence and outcomes: a literature review. |
Q36590594 | Hypertension Control and Its Correlates Among Adults Attending a Hypertension Clinic in Tanzania |
Q36190964 | Hypertension and Health Behaviors in Females Across the Lifespan |
Q30539620 | Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis |
Q46648615 | Identification of barriers to medication adherence in a Latino population |
Q55466022 | Impact of Appointment-Based Medication Synchronization on Proportion of Days Covered for Chronic Medications. |
Q37116113 | Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults |
Q93079546 | Impact of a Pharmacy-Led Transition of Care Service on Post-Discharge Medication Adherence |
Q36411739 | Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia |
Q36841956 | Impact of disease management on utilization and adherence with drugs and tests: the case of diabetes treatment in the Florida: a Healthy State (FAHS) program |
Q33652884 | Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes |
Q38650936 | Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain |
Q33931931 | Impact of prescription benefit coverage limits on sevelamer hydrochloride adherence for patients with ESRD. |
Q33573537 | Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes |
Q79431828 | Impacts of diabetes and hypertension on the risk of hospitalization among less educated people |
Q42684361 | Implementing health promotion activities using community-engaged approaches in Asian American faith-based organizations in New York City and New Jersey |
Q47213135 | Importance of Active Participation in Obesity Management Through Mobile Health Care Programs: Substudy of a Randomized Controlled Trial. |
Q33852705 | Importance of including early nonadherence in estimations of medication adherence |
Q30850706 | Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy |
Q39427698 | Improving Adherence to Treatment and Reducing Economic Costs of Hypertension: The Role of Olmesartan-Based Treatment |
Q36431538 | Improving Medication Adherence through Graphically Enhanced Interventions in Coronary Heart Disease (IMAGE-CHD): a randomized controlled trial |
Q41155752 | Improving adherence to cardiovascular disease medications with information technology. |
Q36110531 | Improving adherence to medication in adults with diabetes in the United Arab Emirates |
Q37632055 | Improving adherence with medication: a selective literature review based on the example of hypertension treatment. |
Q28081280 | Improving diabetes medication adherence: successful, scalable interventions |
Q33789527 | Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders |
Q34482456 | Improving medication adherence in hypercholesterolemia: challenges and solutions |
Q49326401 | Improving medication adherence: a framework for community pharmacy-based interventions |
Q34914590 | Improving post-discharge medication adherence in patients with CVD: a pilot randomized trial |
Q36776947 | Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management |
Q35200266 | Improving the validity of determining medication adherence from electronic health record medications orders |
Q47831546 | In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. |
Q34553899 | Incident user cohorts for assessing medication cost-offsets |
Q43157065 | Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings |
Q36753533 | Increasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce Savings In South Africa |
Q34927764 | Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment |
Q82598269 | Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension |
Q37539630 | Influence of patients' disease knowledge and beliefs about medicines on medication adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine |
Q26781959 | Interventional tools to improve medication adherence: review of literature |
Q86863164 | Interventions aimed at improving performance on medication adherence metrics |
Q47639628 | Investigating the cost implications of including all respiratory medicines in PCRS schemes |
Q34543684 | Is 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland |
Q27008203 | Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review |
Q39880975 | Is there an impatience genotype leading to non-adherence to long-term therapies? |
Q28547957 | Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem |
Q64114036 | Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes |
Q26824261 | Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension |
Q34463260 | Mail-order pharmacy use and adherence to diabetes-related medications |
Q37618888 | Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges. |
Q33866078 | Measuring concurrent adherence to multiple related medications |
Q36279176 | Measuring medication adherence in patients with incident hypertension: a retrospective cohort study |
Q90454117 | Measuring the multiple domains of medication nonadherence: findings from a Delphi survey of adherence experts |
Q35757238 | Medical expenditures among immigrant and nonimmigrant groups in the United States: findings from the Medical Expenditures Panel Survey (2000-2008) |
Q36270909 | Medicare Star excludes diabetes patients with poor CVD risk factor control |
Q36964650 | Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension |
Q47105728 | Medication Management Apps: Usable by Older Adults? |
Q37368937 | Medication Management: The Macrocognitive Workflow of Older Adults With Heart Failure. |
Q90644018 | Medication Non-Adherence among Patients with Heart Failure |
Q36386474 | Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus |
Q39455827 | Medication Nonadherence: The Role of Cost, Community, and Individual Factors |
Q37315597 | Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy. |
Q43198230 | Medication adherence after myocardial infarction: a long way left to go. |
Q37672513 | Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in southwestern Nigeria |
Q38874465 | Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study |
Q43214543 | Medication adherence and beyond: Blood pressure control and the pharmacist |
Q41544336 | Medication adherence and glycemic control among newly diagnosed diabetes patients |
Q33553710 | Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system |
Q35063975 | Medication adherence and readmission after myocardial infarction in the Medicare population |
Q33602572 | Medication adherence as a predictor of 30-day hospital readmissions |
Q42910829 | Medication adherence behaviors of Medicare beneficiaries |
Q36853861 | Medication adherence in chronic disease: issues in posttransplant immunosuppression |
Q45330804 | Medication adherence in combat veterans with traumatic brain injury |
Q37987872 | Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. |
Q36931621 | Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in Brazil |
Q37269750 | Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland |
Q35780492 | Medication adherence in type 2 diabetes patients: study of patients in Alimosho General Hospital, Igando, Lagos, Nigeria |
Q34189448 | Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study |
Q33645086 | Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure |
Q38732538 | Medication adherence: staying within the boundaries of safety |
Q59087859 | Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care |
Q33551583 | Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid |
Q36491786 | Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults |
Q37037429 | Medication nonadherence: an unrecognized cardiovascular risk factor |
Q92006093 | Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital |
Q36861986 | Medication therapy management and adherence among US renal transplant recipients |
Q99711254 | Medication-Related Burden and Medication Adherence Among Geriatric Patients in Kuwait: A Cross-Sectional Study |
Q37606776 | Medicines Compliance and Reimbursement Level in Portugal. |
Q89915310 | Medicines as a Service: A New Commercial Model for Big Pharma in the Postblockbuster World |
Q30694151 | Missing signposts on the roadmap to quality: a call to improve medication adherence indicators in data collection for population research |
Q85354889 | Mitigating the Burden of Type 2 Diabetes: Challenges and Opportunities |
Q26744065 | Mode of administration of dulaglutide: implications for treatment adherence |
Q57298246 | Monte Carlo Simulations Demonstrate Algorithmic Interventions Over Time Reduce Hospitalisation in Patients With Schizophrenia and Bipolar Disorder |
Q34402022 | Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study) |
Q92427298 | Naturally Occurring Expressive Suppression is Associated with Lapses in Instrumental Activities of Daily Living Among Community-Dwelling Older Adults |
Q37309558 | New medication adherence scale versus pharmacy fill rates in seniors with hypertension |
Q35106539 | Non-adherence in patients on peritoneal dialysis: a systematic review. |
Q36669031 | Non-adherence in type 2 diabetes: practical considerations for interpreting the literature |
Q34084953 | Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study. |
Q37328563 | Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease |
Q36480601 | Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis |
Q40081065 | Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case study |
Q35555613 | Obedience and motivation as mechanisms for adherence to medication: a study in obese type 2 diabetic patients |
Q83314391 | Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study |
Q37362262 | Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure |
Q37332526 | Older adults and mobile phones for health: a review. |
Q96224814 | Older patients and geographic barriers to pharmacy access: When nonadherence translates to an increased use of other components of health care |
Q37077938 | One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study |
Q93020422 | Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study |
Q45375703 | Opportunities to reduce medication regimen complexity: a retrospective analysis of patients discharged from a university hospital in Germany |
Q37528565 | Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial |
Q41080901 | Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec |
Q89963464 | Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences |
Q51898927 | Parent Support, Peer Support, and Peer Acceptance in Healthy Lifestyle for Asthma Management Among Early Adolescents |
Q47753691 | Patient Adherence to Dysphagia Recommendations: A Systematic Review |
Q92704130 | Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence |
Q41864289 | Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases |
Q36553220 | Patient complexity and risk factor control among multimorbid patients with type 2 diabetes: results from the R2D2C2 study |
Q38673107 | Patient compliance with venous thromboembolism prophylaxis (VTE). |
Q35324149 | Patient medication adherence: measures in daily practice |
Q38255156 | Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings |
Q39090049 | Patient-centered priorities for improving medication management and adherence |
Q37634700 | Patients' Adherence to Anti-Diabetic Medications in a Hospital at Ajman, UAE. |
Q37653909 | Patients' Expectations Regarding Medical Treatment: A Critical Review of Concepts and Their Assessment |
Q37012846 | Patterns of nonadherence to antihypertensive therapy in primary care |
Q38573121 | Peers as Facilitators of Medication Adherence Interventions: A Review |
Q33878804 | Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort |
Q36729617 | Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study |
Q47558487 | Persons with disability, social deprivation and an emergency medical admission |
Q33932273 | Perspectives in value-based insurance design for patients with diabetes: assessment and application |
Q90214703 | Pharmacist Clinical Interventions and Discharge Counseling in Medical Rehabilitation Wards in a Local Hospital: A Prospective Trial |
Q84797068 | Pharmacist Counseling at the Start of Therapy: Patient Receptivity to Offers of In-Person and Subsequent Telephonic Clinical Support |
Q50050645 | Pharmacist-based antihypertensive medication review and assignment of morning versus evening dosing of once-daily antihypertensive medications: A pilot study to assess feasibility and efficacy in chronic kidney disease patients |
Q64971297 | Pharmacist-led medication non-adherence intervention: reducing the economic burden placed on the Australian health care system. |
Q90823321 | Pharmacogenomic-Based Decision-Support to Predict Adherence to Medications |
Q33932219 | Physicians' perceptions of reimbursement as a barrier to comprehensive diabetes care |
Q34332770 | Placebo adherence and its association with morbidity and mortality in the studies of left ventricular dysfunction |
Q50194702 | Population health management: An independent physician organization approach |
Q37177541 | Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis |
Q88249238 | Poverty, Transportation Access, and Medication Nonadherence |
Q36822237 | Predicting Noninsulin Antidiabetic Drug Adherence Using a Theoretical Framework Based on the Theory of Planned Behavior in Adults With Type 2 Diabetes: A Prospective Study. |
Q40027475 | Predictors of antihypertensive medication adherence in two urban health-care systems |
Q37954176 | Predictors of medication adherence in an urban Latino community with healthcare disparities |
Q37016847 | Predictors of medication adherence using a multidimensional adherence model in patients with heart failure |
Q97644849 | Predictors of poor adherence to antidiabetic therapy in patients with type 2 diabetes: a cross-sectional study insight from Ethiopia |
Q92481120 | Predictors of primary non-adherence to concomitant chronic treatment in HIV-infected patients with antiretroviral therapy |
Q60952960 | Predictors of β-blocker adherence in cardiac inherited disease |
Q58083235 | Prescription fill rates for acute and chronic medications in claims-EMR linked data |
Q36299518 | Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension |
Q53523424 | Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. |
Q42555717 | Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? |
Q34712375 | Primary medication non-adherence after discharge from a general internal medicine service. |
Q24619145 | Primary medication non-adherence: analysis of 195,930 electronic prescriptions |
Q47094676 | Protocol for project IMPACT (improving millions hearts for provider and community transformation): a quasi-experimental evaluation of an integrated electronic health record and community health worker intervention study to improve hypertension manag |
Q47740464 | Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication. |
Q24186763 | Providing physicians with feedback on medication adherence. Effect on processes of care and patient outcomes |
Q41875550 | Quality of Life and Medication Adherence of Independently Living Older Adults Enrolled in a Pharmacist-Based Medication Management Program |
Q33766337 | Quality of care associated with common chronic diseases in a 9-state Medicaid population utilizing claims data: an evaluation of medication and health care use and costs |
Q58597659 | Quantifying Social Reinforcement Among Family Members on Adherence to Medications for Chronic Conditions: a US-Based Retrospective Cohort Study |
Q37086603 | Racial differences in medication adherence: A cross-sectional study of Medicare enrollees |
Q42612111 | Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure. |
Q37523123 | Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. |
Q36173141 | Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence |
Q36809906 | Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study |
Q92098140 | Recall of Pharmaceutical Pictograms by Older Adults |
Q26775544 | Reducing Medication Costs to Prevent Cardiovascular Disease: A Community Guide Systematic Review |
Q37473761 | Reducing adverse self-medication behaviors in older adults with the Next Generation Personal Education Program (PEP-NG): Design and methodology |
Q62516363 | Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland |
Q34944879 | Reinforcing adherence to antihypertensive medications |
Q40111327 | Relationship Between Health Literacy and Unintentional and Intentional Medication Nonadherence in Medically Underserved Patients With Type 2 Diabetes |
Q37635739 | Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan |
Q39096072 | Relationships as Medicine: Quality of the Physician-Patient Relationship Determines Physician Influence on Treatment Recommendation Adherence |
Q45933478 | Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes. |
Q55288083 | Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice. |
Q41979116 | Revisiting the internal consistency and factorial validity of the 8-item Morisky Medication Adherence Scale. |
Q37637922 | Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery |
Q34407859 | Risk of hospitalization for diabetic macrovascular complications and in-hospital mortality with irregular physician visits using propensity score matching |
Q51872425 | Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. |
Q89399239 | Role of the Pharmacoeconomic Aspects in the Clinical Management of Hypertension |
Q34782693 | Safety and effectiveness of mail order pharmacy use in diabetes |
Q34786481 | Secondary prevention by enhancing adherence in diabetic patients. |
Q35969028 | Self-Assessment of Adherence to Medication: A Case Study in Campania Region Community-Dwelling Population. |
Q44580534 | Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients |
Q35536242 | Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery |
Q37394557 | Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes |
Q89530934 | Social Risk Factors for Medication Nonadherence: Findings from the CARDIA Study |
Q37056092 | Social network resources and management of hypertension |
Q46424466 | Strategies to improve drug adherence |
Q87802084 | Strengthening value-based medication management in a free clinic for the uninsured: Quality interventions aimed at reducing costs and enhancing adherence |
Q34258198 | Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study |
Q36656265 | Symptoms of depression and anxiety and adherence to antihypertensive medication |
Q38389745 | Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence. |
Q36331098 | Systemic Arterial Hypertension in the Emergency Service: medication adherence and understanding of this disease. |
Q38707976 | Systolic Blood Pressure and Biochemical Assessment of Adherence: A Cross-Sectional Analysis in the Emergency Department |
Q47687604 | Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence |
Q26823088 | Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development |
Q36066102 | Teaching medication adherence in US colleges and schools of pharmacy |
Q64105213 | Temporal effectiveness of interventions to improve medication adherence: A network meta-analysis |
Q37485725 | Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure |
Q33454501 | Text Messaging and Mobile Phone Apps as Interventions to Improve Adherence in Adolescents With Chronic Health Conditions: A Systematic Review |
Q37593511 | The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial |
Q37561716 | The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control |
Q36627177 | The Association of Complementary Therapy Use With Prescription Medication Adherence Among Older Community-Dwelling Adults |
Q64120882 | The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies |
Q47589117 | The Effect Of Medicaid On Medication Use Among Poor Adults: Evidence From Oregon |
Q36784590 | The Effectiveness of Medication Adherence Interventions Among Patients With Coronary Artery Disease: A Meta-analysis |
Q39973550 | The Lorenzini Foundation in a changing scenario of patient management |
Q35536685 | The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia |
Q37156881 | The Office Guidelines Applied to Practice program improves secondary prevention of heart disease in Federally Qualified Healthcare Centers |
Q33799791 | The Role of Dentists and Primary Care Physicians in the Care of Patients with Sleep-Related Breathing Disorders |
Q92712776 | The Role of Occupational Therapy in Secondary Prevention of Diabetes |
Q35909026 | The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology |
Q34771556 | The accuracy of self-reported drug ingestion histories in emergency department patients |
Q34071372 | The association of depression with adherence to antihypertensive medications: a systematic review |
Q37722653 | The association of smoking with medical treatment adherence in the workforce of a large employer |
Q35606859 | The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users |
Q36573967 | The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review |
Q87286329 | The effect of chairside chronic disease screenings by oral health professionals on health care costs |
Q26829072 | The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis |
Q33706848 | The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management |
Q88933105 | The effectiveness of culturally tailored video narratives on medication understanding and use self-efficacy among stroke patients: A randomized controlled trial study protocol |
Q33916917 | The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial |
Q26864768 | The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. |
Q35190976 | The impact of Medicare Part D on hospitalization rates |
Q34295474 | The impact of adherence on costs and effectiveness of telemedical patient management in heart failure: a systematic review |
Q90707954 | The impact of patient-centered medical homes on medication adherence? |
Q35922120 | The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. |
Q33892516 | The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial |
Q37496481 | The influence of frailty syndrome on medication adherence among elderly patients with hypertension. |
Q50583634 | The influence of patients' knowledge on adherence to their chronic medications: a cross-sectional study in Jordan. |
Q37671210 | The potential impact of pharmacogenetic testing on medication adherence |
Q37163615 | The predictors to medication adherence among adults with diabetes in the United Arab Emirates |
Q37266094 | The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries |
Q55546682 | The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review. |
Q36432150 | The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review |
Q37667519 | Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: a systematic review and meta-analysis |
Q41835397 | Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program |
Q37434768 | Treatment Intensification for Hypertension in US Ambulatory Medical Care |
Q38205890 | Treatment adherence in patients with headache: a systematic review |
Q36887559 | Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis |
Q80379008 | Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia |
Q33835762 | Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide |
Q45003081 | Trends in Prescription and Determinants of Persistence to Antihypertensive Therapy : The PAPEETE Study |
Q37187904 | Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients |
Q34953788 | Understanding patients' perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review |
Q49884757 | Use of Western Medicine and Traditional Korean Medicine for Joint Disorders: A Retrospective Comparative Analysis Based on Korean Nationwide Insurance Data. |
Q47139165 | Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal |
Q36654014 | Use of pictorial aids in medication instructions: a review of the literature |
Q35855191 | Using machine learning to examine medication adherence thresholds and risk of hospitalization |
Q37184314 | Using quantile regression to assess disparities in medication adherence |
Q37516626 | Validated adherence scales used in a measurement-guided medication management approach to target and tailor a medication adherence intervention: a randomised controlled trial |
Q49591826 | Validation of the English and French versions of the Brief Health Care Climate Questionnaire |
Q37810914 | Valsartan–amlodipine–hydrochlorothiazide: the definitive fixed combination? |
Q36244241 | Variation in medication adherence across patient behavioral segments: a multi-country study in hypertension |
Q37404098 | Veterans Affairs research on health information technologies for diabetes self-management support |
Q37635197 | What are validated self-report adherence scales really measuring?: a systematic review. |
Q33932263 | When information is insufficient: inspiring patients for medication adherence and the role of social support networking |
Q46495340 | When more is not better: treatment intensification among hypertensive patients with poor medication adherence |
Q36572804 | Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification |
Q83291166 | [Medication adherence in patients with chronic diseases: significance and new approaches] |
Search more.